Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Companion Diagnostic Companies

Companion diagnostics are medical tests or devices that are developed alongside specific drugs to help determine the most effective treatment for individual patients. These tests identify biomarkers or genetic markers that are essential for predicting the safety and efficacy of a particular therapy.

Companion Diagnostics Key CompaniesDisclaimer: List of key companies in no particular orderLatest Companion diagnostics Media Companies Update



  • June 2023: The upgraded xCELLigence RTCA Software Pro Version 2.8, a complete software suite for executing and analyzing real-time cell analysis data, has been released, according to US-based Agilent Technologies Inc. Agilent xCELLigence Real-Time Cell Analysis (RTCA) equipment can be used in GMP-regulated facilities thanks to this enhanced version. The xCELLigence RTCA Software Pro makes data integrity controls possible to comply with the FDA 21 CFR Part 11 and EU GMP Annex 11 regulations for digital records and electronic signatures, which are crucial for manufacturing pharmaceuticals and biopharmaceuticals. New and improved capabilities guarantee the authenticity, dependability, and trustworthiness of data and electronic records created with xCELLigence RTCA systems and their compliance with GMP production standards.




  • Oct 2023: The global leader in in vitro diagnostics, bioMérieux SA, has invested £70 million in Oxford Nanopore Technologies plc. Oxford Nanopore, which was formed from the University of Oxford lab of Professor Hagan Bayley, has created a real-time DNA/RNA sequencer that can help with precise, quick testing for infectious diseases and cancer. The business services thousands of clients in over 120 countries, representing a broad spectrum of scientific communities. Currently, the French company bioMérieux holds 3.5% of the company's shares, with plans to raise that percentage "from time to time, subject to availability and price." After the businesses announced their alliance in April, the investment aligns with Oxford Nanopore's growing emphasis on clinical markets.


List of Companion diagnostics Key companies in the market

  • Hoffmann-La Roche Ltd (Switzerland)

  • Thermo Fisher Scientific Inc. (US)

  • Agilent Technologies, Inc. (US)

  • QIAGEN N.V. (Germany)

  • Abbott Laboratories, Inc. (US)

  • BioMérieux SA (France)

  • Leica Biosystems Nussloch GmbH (Germany)

  • Illumina, Inc. (US)

  • Myriad Genetics, Inc. (US)

  • ArcherDX, Inc. (US)

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.